TMEM44-AS1 can sponge miR-2355-5p, leading to upregulation of PPP1R13L expression and inhibition of the P53 pathway to synergistically reverse 5-FU resistance in gastric cancer [24]. Here, TMEM44 is linked to gastric cancer.